Axis Medical is the exclusive distributor of Chemomaker+, the innovative automated chemotherapy drug compounding device
What is ChemoMaker+
Thanks to its automation, it solves the most of critical issues related to the manual preparation process usually adopted in hospitals.
ChemoMaker+ is an innovative technology for the automated compounding process of patient-specific chemotherapy drugs that offers mutliple benefits.
ChemoMaker+ offers an automated compounding procedure, leading to crucial benefits, such as
- increasing patient safety
- lowering operators’ risk of contamination
- reducing operating costs optimizing the use of drugs
- increasing accuracy
- time-efficient, as it can prepare up to 12 patients’ therapy dose at the same time
How it works
The system is based on a robotic unit, able to fully automatize the dosing process (i.e.: the transfer of drugs from vials to infusion bags). Patient doses, ready to be administered, are prepared in a sterile environment, and the compounding robot, is placed under a sterile laminar flow hood. A closed system (patent pending) prevents the contamination.
Accurate medicine doses
The proper formulation is guaranteed by a real-time gravimetric control system (patent pending) able to ensure dosage accuracies up to 1%, more than one order of magnitude higher than the precision allowed by the European Pharmacopoeia in manual preparations.
ChemoMaker+ is wireless connected to a computer, which allows the operators of the hospital pharmacy to organize the preparation activity according to the prescriptions received from the oncology departments. All materials are identified by barcodes and RFID tags for maximum safety. Multiple automatic checks assure high accuracy and safety of the final product.
The drug is dosed directly into the final containers intended for administration (bags, syringes, elastomeric pumps), in order to avoid any subsequent manipulation, preventing contamination for healthcare professionals and patients.
Need a detailed presentation?
tel: 0030 2313 036458
email: [email protected]